SQ Innovation, Inc.: furosemide

(12) We acknowledge your draft labeling submitted on Ls cigicgeraieciort We reserve further comment on the proposed labeling until the application is otherwise adequate.

Submit draft carton and container labeling based on our proposed revisions date:

If your user interface is revised in response to the Complete Response, additional human factors considerations may apply.